GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Lifevantage Corp (NAS:LFVN) » Definitions » Sloan Ratio %

Lifevantage (Lifevantage) Sloan Ratio %

: -12.12% (As of Dec. 2023)
View and export this data going back to 1997. Start your Free Trial

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Lifevantage's Sloan Ratio for the quarter that ended in Dec. 2023 was -12.12%.

As of Dec. 2023, Lifevantage has a Sloan Ratio of -12.12%, indicating there is a warning stage of accrual build up.


Lifevantage Sloan Ratio % Historical Data

The historical data trend for Lifevantage's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lifevantage Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Sloan Ratio %
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.59 -6.96 0.45 -4.68 -1.86

Lifevantage Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Sloan Ratio % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.36 -5.76 -1.86 -10.38 -12.12

Competitive Comparison

For the Packaged Foods subindustry, Lifevantage's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lifevantage Sloan Ratio % Distribution

For the Consumer Packaged Goods industry and Consumer Defensive sector, Lifevantage's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Lifevantage's Sloan Ratio % falls into.



Lifevantage Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Lifevantage's Sloan Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Sloan Ratio=(Net Income (A: Jun. 2023 )-Cash Flow from Operations (A: Jun. 2023 )
-Cash Flow from Investing (A: Jun. 2023 ))/Total Assets (A: Jun. 2023 )
=(2.54-6.828
--3.059)/66.123
=-1.86%

Lifevantage's Sloan Ratio for the quarter that ended in Dec. 2023 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Dec. 2023 )
=(2.961-13.728
--3.171)/62.682
=-12.12%

Lifevantage's Net Income for the trailing twelve months (TTM) ended in Dec. 2023 was 1.022 (Mar. 2023 ) + 1.966 (Jun. 2023 ) + 0.629 (Sep. 2023 ) + -0.656 (Dec. 2023 ) = $3.0 Mil.
Lifevantage's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2023 was 3.443 (Mar. 2023 ) + 3.763 (Jun. 2023 ) + 4.765 (Sep. 2023 ) + 1.757 (Dec. 2023 ) = $13.7 Mil.
Lifevantage's Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2023 was -0.99 (Mar. 2023 ) + -0.505 (Jun. 2023 ) + -1.133 (Sep. 2023 ) + -0.543 (Dec. 2023 ) = $-3.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lifevantage  (NAS:LFVN) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Dec. 2023, Lifevantage has a Sloan Ratio of -12.12%, indicating there is a warning stage of accrual build up.


Lifevantage Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Lifevantage's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Lifevantage (Lifevantage) Business Description

Traded in Other Exchanges
Address
3300 N. Triumph Boulevard, Suite 700, Lehi, UT, USA, 84043
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system, as well as Canine Health, a companion pet supplement formulated to combat oxidative stress in dogs. Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.
Executives
Darwin Lewis director 9785 S. MONROE STREET, SUITE 300, SANDY UT 84070
Michael A Beindorff director EXCLUSIVE RESORTS, LLC, 1530 16TH STREET, SUITE 500, DENVER CO 80202
Garry Paul Mauro director 6400 S. FIDDLER'S GREEN CIRCLE, SUITE 1970, GREENWOOD VILLAGE X1 80111
Sudbury Capital Fund, Lp other: See Footnote 1 136 OAK TRAIL, COPPELL TX 75019
Bradley Louis Radoff other: See Footnote 1 2727 KIRBY DRIVE, UNIT 29L, HOUSTON TX 77098
Sudbury Capital Management, Llc other: See Footnote 1 136 OAK TRAIL, COPPELL TX 75019
Sudbury Holdings, Llc other: See Footnote 1 136 OAK TRAIL, COPPELL TX 75019
Sudbury Capital Gp, Lp other: See Footnote 1 136 OAK TRAIL, COPPELL TX 75019
Judd Dayton other: See Footnote 1 878 S. DENTON TAP RD., SUITE 220, COPPELL TX 75019
Family Foundation Radoff other: See Footnote 1 2727 KIRBY DRIVE, UNIT 29L, HOUSTON TX 77098
Julie Boyster officer: Chief Marketing Officer 3300 N. TRIUMPH BLVD, SUITE 700, LEHI UT 84043
Kristen Cunningham officer: Chief Sales Officer 3300 N. TRIUMPH BLVD, SUITE 700, LEHI UT 84043
Cynthia Latham director 3300 N. TRIUMPH BLVD., SUITE 700, LEHI UT 84043
Carl Aure officer: Chief Financial Officer 3300 N. TRIUMPH BLVD., SUITE 700, LEHI UT 84043
Alissa Neufeld officer: General Counsel 3300 TRIUMPH BLVD, SUITE 700, LEHI UT 84043